Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06179017Not ApplicableActive Not Recruiting

Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion

Role: lead

NCT07035392Phase 2Not Yet Recruiting

Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

Role: lead

NCT06505512Recruiting

A Study of Enterorenal Syndrome Assessed by Gastrointestinal Ultrasound Combined with Renal Artery Resistance Index

Role: lead

NCT06478264Phase 2Not Yet Recruiting

A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma

Role: lead

NCT06458348Not ApplicableNot Yet Recruiting

Local Opera Viewing Combined Medical Gymnastics for Elderly PSCI

Role: lead

All 5 trials loaded